(2008). Hormone replacement therapy use and the risk of stroke. Maturitas. http://doi.org/10.1016/j.maturitas.2008.09.020.
(2010). Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near death: a nested case-control study. Bmj. http://doi.org/10.1136/bmj.c249.
(2010). Hormone replacement therapy and the risk of venous thromboembolism: a population-based study. J Thromb Haemost. http://doi.org/10.1111/j.1538-7836.2010.03839.x.
(2010). Thiazolidinediones and the risk of incident strokes in patients with type 2 diabetes: a nested case-control study. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.1883.
(2010). Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study. Bmj. http://doi.org/10.1136/bmj.c2519.
(2011). Risk of herpes zoster in patients prescribed inhaled corticosteroids: a cohort study. BMC Pulm Med. http://doi.org/10.1186/1471-2466-11-59.
(2011). Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer. Br J Cancer. http://doi.org/10.1038/bjc.2011.140.
(2010). Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.1834.
(2011). Metformin and the incidence of prostate cancer in patients with type 2 diabetes. Cancer Epidemiol Biomarkers Prev. http://doi.org/10.1158/1055-9965.epi-10-0940.
(2011). Concurrent use of tamoxifen with CYP2D6 inhibitors and the risk of breast cancer recurrence. Breast Cancer Res Treat. http://doi.org/10.1007/s10549-010-1162-y.